These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


976 related items for PubMed ID: 19105418

  • 1. [Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome].
    Reshetniak TM, Seredavkina nV, Mach ES, Aleksandrova EN, Novikov AA, Cherkasova MV, Nasonov EL.
    Ter Arkh; 2008; 80(10):60-7. PubMed ID: 19105418
    [Abstract] [Full Text] [Related]

  • 2. [The role of hyperhomocysteinemia in systemic lupus erythematosus and antiphospholipid syndrome].
    Reshetniak TM, Shirokova IE, Lisitskaia TL.
    Ter Arkh; 2006; 78(6):24-30. PubMed ID: 16881359
    [Abstract] [Full Text] [Related]

  • 3. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM.
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [Abstract] [Full Text] [Related]

  • 4. IgG anti-beta(2) glycoprotein I antibodies in Malaysian patients with antiphospholipid syndrome and systemic lupus erythematosus: prevalence and clinical correlations.
    Ong SG, Cheng HM, Soon SC, Goh E, Chow SK, Yeap SS.
    Clin Rheumatol; 2002 Sep; 21(5):382-5. PubMed ID: 12223986
    [Abstract] [Full Text] [Related]

  • 5. [Antiphospholipid syndrome and stroke].
    Kitagawa Y.
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [Abstract] [Full Text] [Related]

  • 6. [Antibodies to various phospholipids in SLE patients with primary antiphospholipid syndrome].
    Reshetniak TM, Boĭtsekhovskaia B, Alekberova ZS, Kalashnikova LA, Mach ES, Zabek Ia.
    Klin Med (Mosk); 1999 Nov; 77(5):32-7. PubMed ID: 10394784
    [Abstract] [Full Text] [Related]

  • 7. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A, de Azevedo MN, de Souza Papi JA, Petri M.
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [Abstract] [Full Text] [Related]

  • 8. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus.
    Somers E, Magder LS, Petri M.
    J Rheumatol; 2002 Dec; 29(12):2531-6. PubMed ID: 12465147
    [Abstract] [Full Text] [Related]

  • 9. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
    Muñoz-Rodríguez FJ, Reverter JC, Font J, Tàssies D, Cervera R, Espinosa G, Carmona F, Balasch J, Ordinas A, Ingelmo M.
    Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121
    [Abstract] [Full Text] [Related]

  • 10. [Leiden, G20210A mutations in prothrombin gene and antiphospholipid antibodies in systemic lupus erythematosus and antiphospholipid syndrome].
    Reshetniak TM, Patrushev LI, Stukacheva EA, Miroshnikov AI, Tikhonova TL, Nasonov EL, Alekberova ZS.
    Ter Arkh; 2000 Jun; 72(5):34-8. PubMed ID: 11109617
    [Abstract] [Full Text] [Related]

  • 11. Influence of antiphospholipid antibody levels and type on thrombotic manifestations: results from the Serbian National Cohort Study.
    Stojanovich L, Markovic O, Marisavljevic D, Elezovic I, Ilijevski N, Stanisavljevic N.
    Lupus; 2012 Mar; 21(3):338-45. PubMed ID: 21993381
    [Abstract] [Full Text] [Related]

  • 12. Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus.
    Tarr T, Lakos G, Bhattoa HP, Szegedi G, Shoenfeld Y, Kiss E.
    Lupus; 2007 Mar; 16(5):324-8. PubMed ID: 17576733
    [Abstract] [Full Text] [Related]

  • 13. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Danowski A, Kickler TS, Petri M.
    J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
    [Abstract] [Full Text] [Related]

  • 14. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML, Gomez S, Pareja JF, Theodoridou A, Sanna G, Hughes GR, Khamashta MA.
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [Abstract] [Full Text] [Related]

  • 15. [Osteonecroses in systemic lupus erythematosus and antiphospholipid syndrome].
    Reshetniak TM, Lisitsyna TA, Nasonov EL.
    Klin Med (Mosk); 2004 Nov; 82(6):46-51. PubMed ID: 15344691
    [Abstract] [Full Text] [Related]

  • 16. [Corticosteroids in the treatment of secondary antiphospholipid syndrome].
    Reshetniak TM, Aleksandrova EN, Alekberova ZS, Mach ES, Nasonov EL.
    Klin Med (Mosk); 2002 Nov; 80(6):17-21. PubMed ID: 12138794
    [Abstract] [Full Text] [Related]

  • 17. Longitudinal determination of antiphospholipid antibodies in lupus patients without previous manifestations of antiphospholipid syndrome. A prospective study.
    de Bandt M, Benali K, Guillevin L, Hachulla E, Job C, Fautrel B, Fournié G, Bonnet C, Fournié B, Le Goff P, Jorgensen C, Meyer O.
    J Rheumatol; 1999 Jan; 26(1):91-6. PubMed ID: 9918247
    [Abstract] [Full Text] [Related]

  • 18. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.
    von Scheven E, Glidden DV, Elder ME.
    Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489
    [Abstract] [Full Text] [Related]

  • 19. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D, Mandl LA, Erkan D, Yin W, Peerschke EI, Salmon JE.
    Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
    [Abstract] [Full Text] [Related]

  • 20. [Soluble CD40 ligand in systemic lupus erythematosus and antiphospholipid syndrome].
    Aleksandrova EN, Novikov AA, Popkova TV, Reshetniak TM, Novikova DS, Kliukvina NG, Il'ina AE, Mach ES, Volkov AV, Nasonov EL.
    Ter Arkh; 2006 Mar; 78(6):35-9. PubMed ID: 16881361
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 49.